dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Pozo Rosich, Patricia |
dc.contributor.author | Lucas, Christian |
dc.contributor.author | Watson, David P. B. |
dc.contributor.author | Gaul, Charly |
dc.contributor.author | Ramsden, Emma |
dc.contributor.author | Ritter, Shannon |
dc.date.accessioned | 2022-05-02T11:55:49Z |
dc.date.available | 2022-05-02T11:55:49Z |
dc.date.issued | 2021-12 |
dc.identifier.citation | Pozo-Rosich P, Lucas C, Watson DPB, Gaul C, Ramsden E, Ritter S, et al. Burden of Migraine in Patients With Preventive Treatment Failure Attending European Headache Specialist Centers: Real-World Evidence From the BECOME Study. Pain Ther. 2021 Dec;10:1691–1708. |
dc.identifier.issn | 2193-651X |
dc.identifier.uri | https://hdl.handle.net/11351/7417 |
dc.description | Migranya; Fracàs del tractament; Productivitat laboral |
dc.description.sponsorship | This study was funded by Novartis Pharma AG, Basel, Switzerland. The study sponsor participated in the study design, data collection, data review, data analysis and writing of the report. The Rapid Service Fee was funded by Novartis Pharma AG, Basel, Switzerland. |
dc.language.iso | eng |
dc.publisher | Springer |
dc.relation.ispartofseries | Pain and Therapy;10 |
dc.rights | Attribution-NonCommercial 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ |
dc.source | Scientia |
dc.subject | Migranya - Tractament |
dc.subject | Avaluació de resultats (Assistència sanitària) |
dc.subject.mesh | Migraine Disorders |
dc.subject.mesh | /drug therapy |
dc.subject.mesh | Treatment Failure |
dc.title | Burden of Migraine in Patients With Preventive Treatment Failure Attending European Headache Specialist Centers: Real-World Evidence From the BECOME Study |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1007/s40122-021-00331-3 |
dc.subject.decs | trastornos migrañosos |
dc.subject.decs | /farmacoterapia |
dc.subject.decs | fracaso del tratamiento |
dc.relation.publishversion | https://doi.org/10.1007/s40122-021-00331-3 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Pozo-Rosich P] Unitat de Cefalees, Servei de Neurologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Grup de Recerca en Cefalees i Dolors Neurològics, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain. [Lucas C] Pain Clinic, Service de Neurochirurgie, Hôpital Salengro, CHU de Lille, 59037 Lille Cedex, France. [Watson DPB] Hamilton Medical Group, Aberdeen AB15 4ZT, Scotland. [Gaul C] Migraine and Headache Clinic Königstein, 61462 Königstein im Taunus, Germany. [Ramsden E] Novartis Pharma AG, 4033 Basel, Switzerland. [Ritter S] Novartis Pharmaceuticals Corporation, East Hanover, NJ 07936, USA |
dc.identifier.pmid | 34643891 |
dc.identifier.wos | 000706941200001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |